September 23, 2024 – FDA on Friday approved FluMist is a flu vaccine that you simply or a caregiver can now administer at home – without the necessity for a health care provider. It's the primary flu vaccine of its kind to supply a needle-free, easy and convenient option, and its manufacturer hopes it should improve access and acceptance.
FluMist incorporates a weakened, harmless version of the flu virus and should be taken every year. The flu, as you most likely know, may cause symptoms resembling fever, stuffy nose, sore throat, cough, body aches and tiredness. It mostly occurs in the autumn and winter and affects hundreds of thousands of individuals annually. FluMist protects against two common flu virus types, A and B, and is suitable for anyone aged 2 to 49. You can still get it from a health care provider in case you prefer, but now you may also decide to have a caregiver who is eighteen or older to assist you at home.
According to MedImmune, the AstraZeneca subsidiary that makes FluMist, studies have shown that individuals ages 18 to 49 can successfully administer the vaccine and that it’s just as effective as when administered by a health care provider or nurse. Iskra Reic, executive vp at AstraZeneca, hopes this authorization will make it easier for families and communities to access the flu vaccine on their very own – outside of traditional health care settings. Peter Marks, MD, PhD, who directs the FDA's Center for Biologics Evaluation and Research, said this authorization opens up more convenient options for individuals who need to protect themselves from the flu.
Anyone who wants to make use of FluMist at home still needs a prescription. But there’s excellent news: a web-based pharmacy will soon offer the vaccine. AstraZeneca said that after completing a screening process to verify eligibility, patients will receive their prescription and have FluMist delivered on to their door, together with detailed instructions on storage and use. FluMist will even proceed to be available in doctors' offices and pharmacies.
For children ages 2 to 17, the FDA recommends that a caregiver administer the spray. Common unwanted side effects include a runny or stuffy nose, fever in younger children, and sore throat in adults.
